Clinical trial
Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
NCT00039104
Study timeline
Study start (unknown)2002-04-01Date precision: month
Registry last updated2013-06-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Adenocarcinoma of the Prostateunresolved
Recurrent Prostate Cancerunresolved
Stage IV Prostate Cancerunresolved
Interventions
rebimastatDRUG
zoledronic acidDRUG · verified · RxNorm: zoledronic acid
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00039104 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.